Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells.

Braadland PR, Ramberg H, Grytli HH, Urbanucci A, Nielsen HK, Guldvik IJ, Engedal A, Ketola K, Wang W, Svindland A, Mills IG, Bjartell A, Taskén KA.

Mol Cancer Res. 2019 Aug 8. doi: 10.1158/1541-7786.MCR-18-0605. [Epub ahead of print]

PMID:
31395667
2.

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA.

Mol Oncol. 2018 Sep;12(9):1639-1655. doi: 10.1002/1878-0261.12347. Epub 2018 Aug 15.

3.

Role of serum response factor expression in prostate cancer biochemical recurrence.

Prencipe M, Fabre A, Murphy TB, Vargyas E, O'Neill A, Bjartell A, Tasken KA, Grytli HH, Svindland A, Berge V, Eri LM, Gallagher W, Watson RW.

Prostate. 2018 Jul;78(10):724-730. doi: 10.1002/pros.23516. Epub 2018 Apr 2.

PMID:
29608018
4.

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB.

Br J Cancer. 2018 Mar 20;118(6):e11. doi: 10.1038/bjc.2017.470. Epub 2018 Feb 20.

5.

Prognostic markers for colorectal cancer: estimating ploidy and stroma.

Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ.

Ann Oncol. 2018 Mar 1;29(3):616-623. doi: 10.1093/annonc/mdx794.

6.

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB.

Br J Cancer. 2017 Nov 21;117(11):1656-1664. doi: 10.1038/bjc.2017.346. Epub 2017 Oct 3. Erratum in: Br J Cancer. 2018 Feb 20;:.

7.

Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer.

Bilir B, Sharma NV, Lee J, Hammarstrom B, Svindland A, Kucuk O, Moreno CS.

Int J Oncol. 2017 Jul;51(1):223-234. doi: 10.3892/ijo.2017.4017. Epub 2017 May 24.

8.

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.

Vedeld HM, Merok M, Jeanmougin M, Danielsen SA, Honne H, Presthus GK, Svindland A, Sjo OH, Hektoen M, Eknaes M, Nesbakken A, Lothe RA, Lind GE.

Int J Cancer. 2017 Sep 1;141(5):967-976. doi: 10.1002/ijc.30796. Epub 2017 Jun 2.

9.

Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study.

Vatne K, Stensvold A, Myklebust TÅ, Møller B, Svindland A, Kvåle R, Fosså SD.

Acta Oncol. 2017 Oct;56(10):1295-1301. doi: 10.1080/0284186X.2017.1314006. Epub 2017 Apr 19.

PMID:
28422584
10.

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.

Walker SM, Knight LA, McCavigan AM, Logan GE, Berge V, Sherif A, Pandha H, Warren AY, Davidson C, Uprichard A, Blayney JK, Price B, Jellema GL, Steele CJ, Svindland A, McDade SS, Eden CG, Foster C, Mills IG, Neal DE, Mason MD, Kay EW, Waugh DJ, Harkin DP, Watson RW, Clarke NW, Kennedy RD.

Eur Urol. 2017 Oct;72(4):509-518. doi: 10.1016/j.eururo.2017.03.027. Epub 2017 Apr 10.

11.

Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA.

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R.

Clin Nutr. 2017 Jun;36(3):672-679. doi: 10.1016/j.clnu.2016.06.014. Epub 2016 Jun 30.

12.

PBX3 is a putative biomarker of aggressive prostate cancer.

Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Taskén KA.

Int J Cancer. 2016 Oct 15;139(8):1810-20. doi: 10.1002/ijc.30220. Epub 2016 Jun 25.

13.

Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.

Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA.

Oncotarget. 2016 Jan 12;7(2):1878-94. doi: 10.18632/oncotarget.6479.

14.

Étude prospective randomisée évaluant un protocole de 2 biopsies ciblées par fusion IRM/TRUS en comparaison avec un protocole standard de 12 biopsies écho-guidées.

Baco E, Rud E, Eri L, Oen G, Latkovic L, Svindland A, Eggesbø H, Ukimura O.

Prog Urol. 2015 Nov;25(13):832-3. doi: 10.1016/j.purol.2015.08.231. French. No abstract available.

PMID:
26544425
15.

Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer.

Bruun J, Kolberg M, Ahlquist TC, Røyrvik EC, Nome T, Leithe E, Lind GE, Merok MA, Rognum TO, Bjørkøy G, Johansen T, Lindblom A, Sun XF, Svindland A, Liestøl K, Nesbakken A, Skotheim RI, Lothe RA.

Clin Cancer Res. 2015 Aug 15;21(16):3759-70. doi: 10.1158/1078-0432.CCR-14-3294. Epub 2015 Apr 24.

16.

A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.

Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O.

Eur Urol. 2016 Jan;69(1):149-56. doi: 10.1016/j.eururo.2015.03.041. Epub 2015 Apr 7.

17.

Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?

Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, Lundeby E, Wessel N, Hoff JR, Berg RE, Diep L, Eggesbø HB, Eri LM.

Eur Urol. 2015 Sep;68(3):487-96. doi: 10.1016/j.eururo.2015.02.039. Epub 2015 Mar 23.

18.

Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin.

Røe OD, Oppegaard PA, Revheim ME, Svindland A.

BMJ Case Rep. 2014 Nov 12;2014. pii: bcr2014206225. doi: 10.1136/bcr-2014-206225.

19.

Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.

Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS.

Eur Urol. 2015 Apr;67(4):787-94. doi: 10.1016/j.eururo.2014.08.077. Epub 2014 Sep 17.

PMID:
25240973
20.

Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer.

Baco E, Rud E, Ukimura O, Vlatkovic L, Svindland A, Matsugasumi T, Bernhard JC, Rewcastle JC, Eggesbø HB.

Urol Oncol. 2014 Nov;32(8):1300-7. doi: 10.1016/j.urolonc.2014.07.014. Epub 2014 Sep 2.

PMID:
25189687
21.

Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer.

Baco E, Rud E, Vlatkovic L, Svindland A, Eggesbø HB, Hung AJ, Matsugasumi T, Bernhard JC, Gill IS, Ukimura O.

J Urol. 2015 Feb;193(2):466-72. doi: 10.1016/j.juro.2014.08.084. Epub 2014 Aug 20.

PMID:
25150643
22.

Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer.

Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB.

World J Urol. 2015 Jul;33(7):1015-21. doi: 10.1007/s00345-014-1362-x. Epub 2014 Jul 25.

23.

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.

Bruun J, Kolberg M, Nesland JM, Svindland A, Nesbakken A, Lothe RA.

Front Oncol. 2014 May 21;4:118. doi: 10.3389/fonc.2014.00118. eCollection 2014.

24.

Thermal fixation of swine liver tissue after magnetic resonance-guided high-intensity focused ultrasound ablation.

Courivaud F, Kazaryan AM, Lund A, Orszagh VC, Svindland A, Marangos IP, Halvorsen PS, Jebsen P, Fosse E, Hol PK, Edwin B.

Ultrasound Med Biol. 2014 Jul;40(7):1564-77. doi: 10.1016/j.ultrasmedbio.2014.02.007. Epub 2014 Apr 24.

PMID:
24768489
25.

Prognostic impact of genomic instability in colorectal cancer.

Hveem TS, Merok MA, Pretorius ME, Novelli M, Bævre MS, Sjo OH, Clinch N, Liestøl K, Svindland A, Lothe RA, Nesbakken A, Danielsen HE.

Br J Cancer. 2014 Apr 15;110(8):2159-64. doi: 10.1038/bjc.2014.133. Epub 2014 Mar 18.

26.

Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone.

Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB.

BJU Int. 2014 Dec;114(6b):E32-E42. doi: 10.1111/bju.12637.

27.

O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.

Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, Svindland A, Schlomm T, Mills IG.

Cancer Res. 2013 Aug 15;73(16):5277-87. doi: 10.1158/0008-5472.CAN-13-0549. Epub 2013 May 29.

28.

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series.

Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, Sjo OH, Mala T, Svindland A, Lothe RA, Nesbakken A.

Ann Oncol. 2013 May;24(5):1274-82. doi: 10.1093/annonc/mds614. Epub 2012 Dec 12.

29.

Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study.

Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S.

Scand J Urol. 2013 Apr;47(2):92-100. doi: 10.3109/00365599.2012.707684. Epub 2012 Aug 6.

PMID:
22860630
30.

Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer.

Sjo OH, Merok MA, Svindland A, Nesbakken A.

Dis Colon Rectum. 2012 Mar;55(3):307-15. doi: 10.1097/DCR.0b013e3182423f62.

PMID:
22469798
31.

The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.

Lazarevic B, Hammarström C, Yang J, Ramberg H, Diep LM, Karlsen SJ, Kucuk O, Saatcioglu F, Taskèn KA, Svindland A.

Br J Nutr. 2012 Dec 28;108(12):2138-47. doi: 10.1017/S0007114512000384. Epub 2012 Mar 8.

PMID:
22397815
32.

Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome.

Sirnes S, Bruun J, Kolberg M, Kjenseth A, Lind GE, Svindland A, Brech A, Nesbakken A, Lothe RA, Leithe E, Rivedal E.

Int J Cancer. 2012 Aug 1;131(3):570-81. doi: 10.1002/ijc.26392. Epub 2011 Oct 20.

33.

Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans.

Lund T, Svindland A, Pepaj M, Jensen AB, Berg JP, Kilhovd B, Hanssen KF.

Diab Vasc Dis Res. 2011 Oct;8(4):284-94. doi: 10.1177/1479164111416831. Epub 2011 Aug 15.

PMID:
21844128
34.

Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer.

Berge V, Berg RE, Hoff JR, Wessel N, Svindland A, Karlsen SJ, Eri LM.

Scand J Urol Nephrol. 2012 Feb;46(1):8-13. doi: 10.3109/00365599.2011.604790. Epub 2011 Aug 15.

PMID:
21843041
35.

Endoscopic snare resection followed by laser ablation in the treatment of large, sessile rectal adenomas.

Nesbakken A, Kristinsson J, Svindland A, Lunde OC.

Scand J Surg. 2011;100(2):99-104.

PMID:
21737385
36.

Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial.

Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ.

Nutr Cancer. 2011;63(6):889-98. doi: 10.1080/01635581.2011.582221. Epub 2011 Jun 29.

PMID:
21714686
37.

Regulation of PBX3 expression by androgen and Let-7d in prostate cancer.

Ramberg H, Alshbib A, Berge V, Svindland A, Taskén KA.

Mol Cancer. 2011 May 6;10:50. doi: 10.1186/1476-4598-10-50.

38.

Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors.

Sjo OH, Berg M, Merok MA, Kolberg M, Svindland A, Lothe RA, Nesbakken A.

J Surg Oncol. 2011 Dec;104(7):792-7. doi: 10.1002/jso.21959. Epub 2011 May 5.

PMID:
21547915
39.

Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer.

Faerden AE, Sjo OH, Bukholm IR, Andersen SN, Svindland A, Nesbakken A, Bakka A.

Dis Colon Rectum. 2011 Feb;54(2):200-6. doi: 10.1007/DCR.0b013e3181fd4c7c.

PMID:
21228669
40.

Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.

Kvåle R, Møller B, Wahlqvist R, Fosså SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ.

BJU Int. 2009 Jun;103(12):1647-54. doi: 10.1111/j.1464-410X.2008.08255.x. Epub 2008 Dec 22.

41.

Development of intimal thickening of coronary arteries over the lifetime of Atlantic salmon, Salmo salar L., fed different lipid sources.

Seierstad SL, Svindland A, Larsen S, Rosenlund G, Torstensen BE, Evensen Ø.

J Fish Dis. 2008 Jun;31(6):401-13. doi: 10.1111/j.1365-2761.2008.00913.x.

PMID:
18471096
42.

Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.

Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA.

Cell Signal. 2007 Feb;19(2):401-9. Epub 2006 Jul 25.

PMID:
16949795
43.

Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice.

Larsen KO, Sjaastad I, Svindland A, Krobert KA, Skjønsberg OH, Christensen G.

Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H507-16. Epub 2006 Mar 31.

44.

[Markers for diagnosis, prediction and prognosis of prostate cancer].

Taskén KA, Angelsen A, Svindland A, Eide T, Berge V, Wahlquist R, Karlsen S.

Tidsskr Nor Laegeforen. 2005 Dec 1;125(23):3279-82. Norwegian.

45.

Influence of dietary lipid composition on cardiac pathology in farmed Atlantic salmon, Salmo salar L.

Seierstad SL, Poppe TT, Koppang EO, Svindland A, Rosenlund G, Frøyland L, Larsen S.

J Fish Dis. 2005 Nov;28(11):677-90.

PMID:
16303029
46.

Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas.

Brandal P, Lie AK, Bassarova A, Svindland A, Risberg B, Danielsen H, Heim S.

Mod Pathol. 2006 Feb;19(2):186-94.

47.

Activity of peroxisomal enzymes, and levels of polyamines in LPA-transgenic mice on two different diets.

Eliassen KA, Brodal BP, Svindland A, Osmundsen H, Rønning H, Djurovic S, Berg K.

Lipids Health Dis. 2005 Oct 4;4:23.

48.

Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.

Korkmaz CG, Korkmaz KS, Kurys P, Elbi C, Wang L, Klokk TI, Hammarstrom C, Troen G, Svindland A, Hager GL, Saatcioglu F.

Oncogene. 2005 Jul 21;24(31):4934-45.

PMID:
15897894
49.

Dynamic first pass 3D EPI of the prostate: accuracy in tumor location.

Storaas T, Gjesdal KI, Svindland A, Viktil E, Geitung JT.

Acta Radiol. 2004 Aug;45(5):584-90.

PMID:
15515524
50.

Atherogenesis and vascular calcification in mice expressing the human LPA gene.

Teivainen PA, Eliassen KA, Berg K, Torsdalen K, Svindland A.

Pathophysiology. 2004 Oct;11(2):113-120.

PMID:
15364123

Supplemental Content

Loading ...
Support Center